Table 3.
Serum values of growth differentiation factor-15 (GDF-15) AFP, and ferritin in controls as and studied groups.
| Parameter | Statistics | Normal control (NC) (N = 20) | Chronic hepatitis C G (I) (N = 20) | Liver cirrhosis G (II) (N = 23) | Hepatocellular carcinoma G (III) (N = 17) |
|---|---|---|---|---|---|
| GFD15 (ng/ml) | Range | 0.30–1.05 | 0.45 – 3.50 | 3.4–6.70 | 4.5–8.79 |
| Mean ± S.E. | 0.70 ± 0.052 | 1.41 ± 0.21 | 5.20 ± 0.21 | 6.49 ± 0.27 | |
| P-value < | <0.01 | <0.001 | <0.001 | ||
| AFP (ng/ml) | Range | 2.1–5.7 | 3.5–9.3 | 13.8–36.4 | 218–351 |
| Mean ± S.E. | 3.88 ± 0.25 | 6.63 ± 0.29 | 28.04 ± 1.85 | 255 ± 7.53 | |
| P-value < | <0.001 | <0.001 | <0.001 | ||
| Ferritin (ng/ml) | Range | 30–203 | 75–273 | 124–382 | 243–764 |
| Mean ± S.E. | 95 ± 11.28 | 162.5 ± 14.13 | 252 ± 16.06 | 504 ± 11.96 | |
| P-value < | <0.001 | <0.001 | <0.001 | ||
P < 0.05 as statistically significant.